Description: From the 1986 Valuation Actuary Symposium, held in Washington DC in October 1986 Discussion of cash flow testing to assess level of C-1,C-2, and C-3 risk. Also, update on regulatory and legislative issues in Canada pertaining to the Valuation Actuary, reserves, and risk based capital

Description: From the 1985 Valuation Actuary Symposium. Discussion on the role of valuation actuary.

Description: From a session at the 2001 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, November 29-30, 2001 Panel discussion overview of current risk-based capital RBC requirements of life insurers, as well as insight into topical issues and potential changes to RBC. Items covered include: • Recap of RBC law and RBC calculation rules • Tax impact on the factors • Common stock issue • C-3 testing • Proposed C-3 testing for Variable Annuity Guaranteed Living Benefits VAGLB • Liquidity risk issue

Description: Panelists: [1] describe the goals, purposes, and current status of the Society of Actuaries' research into the credit risk of commercial mortgages and private-placement bonds, [2] describe the theory behind the new AVR and IMR and how they function, [3] describe their use from the valuation actuary’s perspective, and [4] discuss the potential impact the AVR/IMR may have on investing and accounting decisions. Session 11 of the 1992 Valuation Actuary Symposium.

Description: From a session at the 2002 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, September 19–20, 2002 Discussion of issues and the impact of current statutory valuation requirements for life insurance policies. Requirements covered include the Actuarial Standard of Practice on XXX, Actuarial Guideline AXXX, and Actuarial Guidelines 36 and 37. Products and issues discussed include nonlevel premium or nonlevel benefit insurance e.g., selective term, universal life with secondary guarantees or shadow accounts, determination of X factors, interpretation issues regarding XXX, variable life, and variable universal life, equity-indexed universal life, and the new CSO mortality table.

Description: From the 1986 Valuation Actuary Symposium, held in Washington DC in October 1986 Discussion of emerging practice and regulations of the NAIC and New York Insurance Department with respect to requirements placed on the methods and assumptions used by the valuation actuary in producing the support for the Actuarial Opinion as to the adequacy of reserves for life insurance companies

Description: This presentation is a panel discussion from the 1991 Annual Meeting of the Society of Actuaries, held October 20-23 in Toronto. The panelists discuss strategies employed in Canada and the United States to restructure life insurance costs. They discuss levelized commissions and commission financing, joint ventures and reinsurance, ‘sale’ of strain and loads, statutory liability review, and the effect of tax law changes, including the ‘DAC tax.’ Discussion from participants is included. From the Record of Society of Actuaries, Volume 17, No. 4B.

Description: Discusses the MSVR: its purpose, how it has [or has not] met its purpose – especially for a company invested in high-risk securities – how it will be affected by the proposed valuation-law changes, and how to treat it in the actuarial opinion required by New York Regulation 126. From the 1988 Record of Society of Actuaries, Vol. 14, No. 3.

Description: From the 1985 Valuation Actuary Symposium. A discussion of the principles that should be part of a life insurance valuation. Also discussion of emerging actuarial professional standards of practice and regulatory requirements with respect to methodology for assessing reserve adequacy.

Description: This session is about meeting the needs for financial information in managing an insurance company. Topics include: 1. What are management's basic needs how are they met can financial systems continue to meet the challenge? 2. Are fundamental changes ahead for GAAP reporting? 3. Is it time for mutual companies to provide more meaningful financial information? 4. Can current regulatory reporting meet the needs of the 21st century? 5. Can separate statutory and GAAP systems continue to coexist? 6. Will the United States regulatory environment reduce our global competitiveness? 7. Variance analysis - Why your predictions were wrong - Which variances are acts of God? - Which variances should be blamed on somebody? - How to deal with interest rate fluctuations 8. Market valuation, why? - What questions are being addressed with market valuation